Is oral semaglutide approved in the UK?
Yes. The MHRA approved Wegovy tablets for weight management on 11 June 2026. The licence covers adults with a BMI of at least 30, or at least 27 with a weight-related condition, alongside diet and activity changes. A prescriber must assess suitability.
The approval announcement explicitly said the tablet was not then available through the NHS. A UK licence does not establish NHS funding, local access or stock at SHIFT. Check the current pathway with your clinician. Read the MHRA announcement.
What does 13.6% weight loss actually mean?
In OASIS 4, 307 adults without diabetes were allocated to oral semaglutide 25 mg or placebo. At week 64, estimated average body-weight change was −13.6% with semaglutide and −2.2% with placebo. These are trial averages, not a promise of your result, and body-weight loss is not the same as pure fat loss.
The trial compared the tablet with placebo, not directly with Mounjaro or a Wegovy injection. It cannot establish which option would work best for you. Gastrointestinal adverse events occurred in 74% of the semaglutide group and 42.2% of the placebo group. Read the original OASIS 4 study.
What is different about taking a tablet?
The approved daily dose starts at 1.5 mg and rises through 4 mg, 9 mg and 25 mg, spending at least a month at each level. Follow the prescription and leaflet; do not jump to the headline trial dose yourself.
The MHRA describes taking the tablet whole after at least eight hours without food, with a sip of water, then waiting at least 30 minutes before food or drink. Ask your pharmacist how other morning medicines fit around it. Official dosing information.
A tablet removes the injection, but adds a daily routine. Before choosing, think about your actual mornings: shifts, breakfast, school runs and other medicines. A treatment that looks convenient on paper still needs to fit your day.
Side effects and when to get help
Nausea, vomiting, constipation and diarrhoea are recognised side effects. Tell your prescriber about your medical history and every medicine or supplement you take. Semaglutide is not used during pregnancy or breastfeeding; discuss planned pregnancy with your clinician.
Seek urgent medical advice for severe, persistent abdominal pain, particularly if it reaches your back, sudden vision loss, or symptoms that leave you unable to keep fluids down. Call 999 for a serious allergic reaction with breathing difficulty or swelling of the throat or tongue. NHS semaglutide safety information.
This is not a complete safety checklist or a personal dosing plan. Use the leaflet supplied with your exact product and contact your prescriber or pharmacist about side effects and changes to treatment.
What should you check before paying?
Ask who assesses you, who prescribes and which registered pharmacy dispenses. Get the total price at later doses, any consultation or delivery charges, and the cancellation terms. Ask how you contact someone if side effects make treatment difficult.
Do not mistake an introductory price for the ongoing cost. Ask whether the quoted supply covers four weeks or a calendar month, and whether support is included. Our Wegovy cost guide explains the questions to ask.
No stock available today. This guide is information, not an offer to prescribe or dispense medication. Check the Treatment Centre for current product status and service details.
SHIFT’s take: plan for life around the treatment
The useful question is bigger than “pill or pen?” It is “what helps me keep going on an ordinary Tuesday?” Food you can manage, movement that fits, a place to check in, and someone qualified to contact about the prescription all matter.
SHIFT’s Programme brings practical food, movement and Life Back support together. You can explore it whether your medication comes from elsewhere, you are considering treatment, or you have stopped. Clinical decisions remain with your prescriber.
If you are thinking about stopping, use our coming-off guide to prepare for that conversation. If your provider has become hard to reach, Clinic Gone Quiet explains SHIFT’s support and its boundaries. We do not replace urgent care or your prescribing team.
Questions worth taking to your prescriber
- Is this exact product suitable for my history and other medicines?
- How should I fit it around breakfast and my normal routine?
- Who do I contact between appointments, and when should I seek urgent help?
- What happens if I cannot tolerate it, supply changes, or I want to stop?
- What is included in the continuing cost?
You do not need to arrive with the right answers. You need a clear route to getting them.
Sources and editorial note
By Matt O’Brien, founder of SHIFT Some Timber. Sources checked 20 September 2026. General information, not an individual treatment recommendation. No independent clinical review is claimed.